Skin Patch Burns May Occur During MRI Scans Warns FDA

The FDA has issued a Public Health Advisory about the risk of burns from medicated skin patch drugs during MRI scans, as some of these medications may contain aluminum or other metal that could overheat, causing a potentially serious skin burn around the patch.

According to the notice issued March 5, 2009, more than 25% of the 60 available medication patches, such as the nicotine patch, fentanyl pain patch and other over-the-counter skin patch products, may contain just enough aluminum or other metals in their backing to conduct electricity and overheat during an MRI scan.

Although many of these skin patch drugs contain warnings that they should not be worn during an MRI, the FDA has found that some do not contain any indication that they contain metal and the metal in the backing may not be visible to the patient or doctor.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

“The risk of using a metallic patch during an MRI has been well-established, but the FDA recently discovered that not all manufacturers include a safety warning with their patches,” said Dr. Janet Woodcock of the FDA. “Because the metal in these patches may not be visible and the product labeling may not disclose the presence of metal, patients should tell both their health care professional and their MRI facility that they wear a medicated adhesive patch.”

In January 2009, the FDA discovered Teva Pharmaceutical’s was not warning about the MRI dangers on their generic fentanyl skin patch. Subsequent investigations have found that the warning is also missing from a variety of other products that deliver medications through the skin.

The FDA is looking at the labeling of all medicated patches, to make sure that any of the skin patch medications that contain metal provide appropriate warnings.

Healthcare providers have been urged to warn patients before any MRI scan about the risk of burns from medicated skin patch products and to make sure that they are removed before the exam.

Patients have also been to tell their doctors about any skin patch drugs that are being used.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Judge Outlines Suboxone Tooth Decay Lawsuit Census Requirements
Judge Outlines Suboxone Tooth Decay Lawsuit Census Requirements (Posted yesterday)

To help the parties identify Suboxone lawsuits that can be used as representative samples in early bellwether trials, the federal judge presiding over the litigation has directed the parties to conduct a census of all tooth decay claims.

Cartiva Implant Lawsuits Bolstered by New Study Finding Higher Revision and Failure Rates
Cartiva Implant Lawsuits Bolstered by New Study Finding Higher Revision and Failure Rates (Posted 2 days ago)

Study indicates that nearly 30% of Cartiva patients required revision or removal surgery due to failure of the toe implant, leading researchers to recommend joint fusion surgery as the preferred treatment option.